Infectious Diseases Society of America (IDSA) Position Statement: Why IDSA Did Not Endorse the Community-Acquired Pneumonia Guidelines 2025 Update
Clinical Infectious Diseases · 30.04.2026 · 82 (4) · 622-624
DOI: 10.1093/cid/ciaf625 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 04.12.2025. Verfasst von Michael Klompas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Community-Acquired Infections, Practice Guidelines as Topic, Pneumonia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
The American Thoracic Society recently released updated community-acquired pneumonia (CAP) guidelines. The Infectious Diseases Society of America (IDSA) agreed with 8 of the 10 recommendations in the guidelines but declined to endorse the guidelines because they include recommendations for use of antibiotics in outpatients with comorbidities and inpatients with nonsevere CAP who test positive for respiratory viruses. It is noted in the guidelines that bacterial coinfections are common and that delaying antibiotics may be harmful. IDSA notes, however, that nondiscriminatory use of antibiotics for patients with CAP and positive viral assays confers more risks than benefits. Most patients do not have bacterial coinfections, and briefly withholding antibiotics for patients with nonsevere illness to clarify the diagnosis is safe. In this era of precision medicine, IDSA instead recommends individualized, dynamic decision-making that takes into account each patient´s evolving trajectory, severity of illness and balance of clinical features for and against coinfection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA.
- Brigham and Women's Hospital, Boston, Massachusetts, USA.
- University of South Carolina School of Medicine, Columbia, South Carolina, USA.
- Prisma Health Midlands, Columbia, South Carolina, USA.
- Baylor College of Medicine, Houston, Texas, USA.
- Baylor St. Luke's Medical Center, Houston, Texas, USA.
ORCID-Profile: Michael Klompas, Majdi Al-Hasan, Robert Colgrove, Shira Doron, Thomas File, Natasha N Pettit, Michael Pulia, Sharon Weissman
Zitieren
APA
Klompas, M., Al-Hasan, M., Al Mohajer, M., Colgrove, R., Doron, S., File, T., Pettit, N. N., Pulia, M., & Weissman, S. (2026). Infectious Diseases Society of America (IDSA) Position Statement: Why IDSA Did Not Endorse the Community-Acquired Pneumonia Guidelines 2025 Update. Clinical Infectious Diseases, 82(4), 622-624. https://doi.org/10.1093/cid/ciaf625
Vancouver
Klompas M, Al-Hasan M, Al Mohajer M, Colgrove R, Doron S, File T, et al. Infectious Diseases Society of America (IDSA) Position Statement: Why IDSA Did Not Endorse the Community-Acquired Pneumonia Guidelines 2025 Update. Clinical Infectious Diseases. 2026;82(4):622-624. doi:10.1093/cid/ciaf625
BibTeX
@article{Klompas2026,
author = {Klompas, Michael and Al-Hasan, Majdi and Al Mohajer, Mayar and Colgrove, Robert and Doron, Shira and File, Thomas and Pettit, Natasha N and Pulia, Michael and Weissman, Sharon},
title = {Infectious Diseases Society of America (IDSA) Position Statement: Why IDSA Did Not Endorse the Community-Acquired Pneumonia Guidelines 2025 Update},
journal = {Clinical Infectious Diseases},
year = {2026},
volume = {82},
number = {4},
pages = {622--624},
doi = {10.1093/cid/ciaf625}
}
EUVIMED